A stockbroker who took to his Facebook page to sound off in reaction to a critical online report last year regarding Arena Pharmaceuticals has been fined $5,000 for the outburst via social media.
I'm tackling a new career challenge. Next month I plan to join Novartis Institutes for BioMedical Research (NIBR) in Cambridge, MA, to manage social media. It means that two weeks from today I will end a thrilling experience as executive editor of the life sciences group at FierceMarkets.
Europeans want to tackle one of the boogeymen of social media in pharma--adverse drug event reporting.
Full disclosure: My original intent for writing this post was to get more of our readers to join and participate in FierceBiotech 's LinkedIn group. We've already grown the group...
Bill Gates has added his high-profile name and dollars to the open-science movement, joining other investors in a $35 million financing round for the 5-year-old social network for scientists called ResearchGate.
After I last wrote about Twitter 's impact on biotech, a few FierceBiotech readers responded with skepticism. They weren't so sure that engaging on a microblogging site was a good use of their...
The latest phase of R&D gamification in biopharma has gone live. As planned, German drugmaker Boehringer Ingelheim unveiled a beta version of its Facebook game called Syrum on Thursday in London.